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Majority o f  the bioanalytical or environmental methods do not use just one 
chromatografie or electrophoretic step, but rather involve several sample 
pretreatment steps which simplfy the matrix, and often preconcentrate and 
chem ically modify the analytes. This work surveys typical procedures for sample 
preparation for most commonly analyzed biofluids with particular emphasis 
placed on chemical derivatization o f sulfur amino acids for their determination by 
liquid phase separation techniques. Recent author's laboratory contribution to the 
development o f  sample preparation procedures is merked.
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1. Introduction
The analysis of biological samples presents a variety of problems which 
are common to high performance capillary electrophoresis (HPCE) and high 
performance liquid chromatography (HPLC). These encompass: (1) large 
number of individual compounds in the sample, leading to difficulty in resolving 
the analytes o f interest, (2) the presence of components, such as proteins, that 
can modify the chromatographic or electrophoretic column, (3) low 
concentrations o f exo- or endogenous compounds of interest, leading to 
detection difficulties, and (4) conjugation of analytes to proteins and low 
molecular components of the analysed mixture. Taking under consideration the 
above, it is not surprising that the majority of bioanalytical (environmental) 
methods do not use just one simple HPCE or HPLC separation step, but rather 
involve several sample pretreatment steps which simplify the matrix, and often 
preconcentrate and chemically modify the analytes [1-3], Such approach leads to
a relatively purified material being introduced to the final separation unit, 
making the separation simpler and reliable. There are also several disadvantages 
of this approach namely, multiple steps usually require more lengthy and more 
refined sample handling and there is more chance for errors.
The biological fluids that are most commonly analyzed are plasma and 
urine. Whole blood is less often analyzed, with exception in the case of small 
animals and forensic toxicology where this may be necessary. Bile, sweat, tears, 
milk and saliva can also be analyzed. The ease with which samples can be 
analyzed increases with the degree of fluidity, bone being the most difficult to 
handle and cerebrospinal fluid the easiest.
2. Direct Injection of Biological Fluids
In HPCE there has been considerable interest in performing single-step 
analysis, with direct injection of body fluids on-capillary. This is quite often 
possible because open bare capillaries are less prone to irreversible modification 
by sample matrix components than a packed HPLC column, and even if 
adsorption of some compounds does occur, there are few limits on the use of 
aggressive cleaning procedures. There is very important argument for the 
development of HPCE methodology for direct injection analyses. With direct 
injection from microcompartments within living systems this microanalytical 
technique offers new possibilities for understanding of a variety of life processes 
that could not be studied previously.
Urine and plasma or serum, the most commonly analyzed biofluids, 
present different problems. Urine is generally free of proteins and lipids but 
contains very many components, concentration of which depends largely on the 
diet, and this can account for pushing the resolving power o f the separation unit 
to the limit. Plasma/serum usually contains fewer individual components at high 
concentration, but the presence of a large amounts of proteins and lipids 
constitutes serious challenges. Besides modification of the capillary walls (in 
HPCE) or packing material (in HPLC), there is a strong affinity between 
proteins and analytes, leading to conjugates and direct measurement can miss the 
total content of the analyte and measure only its free fraction. Thus, chemical or 
enzymatic cleavage of conjugated analytes is still necessary in many cases. The 
advice to filter the sample, if possible, through a 0,45 |xm membrane to remove 
any particulate capable of blocking the capillary or column is always valid.
One problem with the urine HPCE analysis is the variable, but generally 
high, concentration of electrolytes. If limits of detection are adequate, the urine 
can be diluted first and then analyzed in moderately concentrated buffer [4J. 
Another means to minimize effects of matrix composition on resolution and
sensitivity is to use high concentration background buffer [5], This requires very 
good cooling system or limited electric field strength leading to longer time of 
analysis without the loss of sensitivity. Both capillary zone electrophoresis 
(CZE) and electrokinetic chromatography (EKC) have been used for direct 
analysis of urine, provided that the analyte concentration is high enough for 
quantitation by detection system. The main problem is to apply a robust method 
with adequate resolution of the analyte from other sample components. In EKC 
with micellar (MEKC) or other pseudostationary phases sample matrix effects 
on the results of analysis seem to be relatively minor [6].
The problems that the high concentration of proteins in plasma (about 70 
g/1) causes in HPCE are double. They adhere to the wall of capillary leading to 
variability of electroosmotic flow (EOF) and peak-broadening. Secondly, the 
broad protein peaks may interfere with analyte peaks. However, several attempts 
of direct injection of plasma were made. It can be done after several fold 
dilution of plasma, provided the background electrolyte is o f high concentration 
17). This approach makes sense only if concentration o f the analyte is high. If 
undiluted plasma is injected, vigorous washings with strong base or acid 
between runs are needed followed by reequilibration in order to achieve good 
EOF repeatibility 18], Addition of sodium dodecyl sulfate to the washing 
solution can accelerate removal of proteins and reequilibration [9J. Since a 
surfactant is present in MEKC by definition, the results of analysis of directly 
injected plasma with this HPCE mode are better than with CZE. In a typical 
MEKC analysis of plasma, the surfactant is strongly bound to the protein, and 
gives it an overall strong negative charge, which reduces interactions with the 
capillary surface and causes strong migration against EOF.
Direct injection of biological samples into the HPLC system causes 
column blockage due to adsorption or precipitation o f proteins. Plasma proteins 
are known to precipitate readily particularly in the pH range 4-8. The signs of 
column deterioration could be such as an increase in column back-pressure, and 
peak splitting or tailing. Columns designed to exclude proteins but allow smaller 
molecules to interact with the stationary phase are available, although their use is 
limited.
3. Traditional Sample Preparation Techniques
Conventional sample preparation techniques, typical scheme of which is 
shown in Fig. 1 are well established and account for the vast majority of HPLC 
procedures for analysis of biological samples. They also feature widely in the 
bioanalytical HPCE literature. A relatively large biofluid sample is needed, 
ranging from a several dozen to a few milliliters. After preparation, a few
microliters to a few milliliters are available for a final analysis. The final 
analysis could be done by HPCE or HPLC. Considering small volume sample 
requirements of HPCE its microanalytical abilities are not utilized. The 
justification for using capillary electrophoresis as the final step of the analytical 
procedure may be its excellent resolving capabilities for analytes which could be 
difficult to separate by HPLC, e.g. diastereoisomers. As shown in Fig. 1 the 
principal steps in sample preparation are extraction, deproteinization, and 
chemical modification.
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Fig. 1. Main steps in the conventional sample preparation procedure
Both liquid-liquid extraction (LLE) and solid-phase extraction (SPE) are 
in use. In LLE, an immiscible organic phase is added to the biological fluid and 
these are then shaken together, resulting in the more hydrophobic sample 
components being extracted into the organic phase. In SPE, the sample is passed 
over a particulate material packed into small disposable columns. Some 
components are retained on the column, and weakly sorbed components may be 
removed by rinsing, followed by elution of strongly retained compounds. In both 
LLE and SPE the analyte concentration is possible by evaporation o f solvent and 
reconstitution of the residue with small volume of desired liquid. This liquid 
could be the HPCE background buffer or HPLC mobile phase. Extraction can be 
done with some degree of specificity.
Many deproteinization methods have been described |10] and the more 
commonly employed are (1) precipitation by addition of organic solvents, (2)
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precipitation by formation of insoluble salts, (3) ultrafiltration, and (4) dialysis. 
Ultrafiltration has an advantage over protein precipitation and dialysis in that it 
is applicable to small volumes and no dilution occurs.
Since there are opportunities for loss of analyte at each step in an off­
line procedure several workers have been looking for clean-up and concentration 
procedures for HPCE either on-capillary, or using a miniaturized system coupled 
to the capillary. A variety of techniques can be used including liquid 
chromatography, electrophoresis and microdialysis or ultrafiltration [11].
Chemical modification encompasses chiefly derivatization of the analyte 
and decomposition of its conjugates with proteins and low molecular endo- or 
exogenous compounds.
4. Thiols as an Analytical Objccts
Thiols play a specific role among reduced sulfur compounds; they are 
chemically and biochemically very active components of the sulfur cycle of the 
natural environment and have been extensively studied in various biological 
systems. Many biological phenomena, among others, redox-, methyl transfer-, 
and carbon dioxide-fixation reactions, are believed to be dependent on the 
presence o f a thiol group. The determination of thiol containing compounds is 
important for biochemical research, in pharmacodynamic studies of the thiol 
drugs, or in the diagnosis of several diseases, e.g. cystinuria and homocystinuria. 
The homocysteine assay is a sensitive tool for early diagnosis of disturbed 
remetylation and transsulfuration leading to hyperhomocysteinemia, which in 
turn is associated with an increased risk of atherothrombotic vascular events 
[12].
The analysis of thiols can be quite perplexing. Aside from the great 
susceptibility to oxidation, which can occur before or during analytical process, 
most thiols lack the structural properties necessary for the production of signals 
compatible with common HPLC or HPCE detectors, such as UV absorbance and 
fluorescence. Therefore, the analyst must resort to derivatization for signal 
enhancement and labile sulfhydryl group blocking if fluorescence or UV-Vis 
detection methods are employed. Numerous reagent are available for the 
derivatization via-SH group and subsequent HPLC or HPCE analysis. A 
majority o f the reagents can be classified by type of the reactive moiety into 
three categories: activated halogen compounds, disulfides, and compounds 
Possessing maleimide moiety, and are reviewed with some experimental details 
>n some excellent works [2, 13]. However, increased demand for measuring 
thiols, mostly biological ones in clinical practice, raises the issue of developing
new methods better suited to accommodate high testing volumes and faster 
turnaround time.
5. Chemical Derivatization of Thiols for HPCE and HPLC
We have developed in our laboratory several thiol specific derivatization 
reagents belonging to the class of azaaromatic compounds with an active 
halogen atom. These are 2-halopyridinium [14] and 2-haloquinolinium salts 
[15], which react rapidly and quantitatively with hydrophilic thiols in slightly 
alkaline water solution to form stable thioethers, S-pyridinium and 
S-quinolinium derivatives, respectively. Fig. 2. Shows the derivatization reaction 
scheme for thiols represented by homocysteine [16] with the use of 2-chloro-l- 
methylquinolinium tetrafluoroborate (CMQT).
Fig. 2. Chemical derivatization reaction equation o f homocysteine with 2-chloro-i- 
methylquinolinium tetrafluoroborate
This derivatization scheme takes advantage of great susceptibility o f the 
quinolinium molecule at 2 position to nucleophilic displacement, and the high 
nucleophilicity of the thiol group. The reaction is accompanied by an 
analytically advantageous bathochromic shift from reagent maximum (328 nm) 
to the maximum of the derivative (348 nm). This phenomena is displayed in 
Fig. 3. Of different functionalities (e.g. -COOH, -NHk -SH) of hydrophilic thiols 
potentially able to undergo nucleophilic attack at the 2-position of quinoline 
(pyridine) molecule, only the sulfhydryl group reacts. This means that no 
multiple derivatives are formed. Under the recommended derivatization 
conditions, formation o f the 2-S-quinolinium derivatives is over within 1 min, 
that is virtually just after mixing substrates.
Based on 2-halopyridinium and 2-haloquinolinium salts as derivatization 
reagents we were able to elaborate several methods for determining endo- 
[14,16-21] and exogenous [20-25] thiols in plasma and urine by manual 
[14,16-25] as well as, fully automatic [26] manner.
The bulk of plasma thiols occur in the disulfide forms rendering them 
inaccessible to derivatization reagent, and in order to determine their total 
contents disulfide bonds must be cleaved with suitable reducing reagent to 
liberate a free thiol. For this purpose sodium borohydride [16],
tri-n-butylphosphine [18,24] or 2-mercaptoethanol [19] was used. Total content 
of thiol is understood as the sum of reduced thiol, free oxidized (dimer and 
mixed disulfides with other endo- and exogenous thiols) and protein bound thiol.
Fig. 3. Three-dimensional chromatogram o f  the derivatization mixture made with continuous 
spectral scanning during the elution. Peaks from right: glutathione -  CMQT, homocysteine -  
CMQT, cysteine -  CMQT, cysteinylglycine -  CMQT derivative and CMQT excess. 
Axis titles: X -  time, Y -  wavenlenght and Z -  absorbance
Among plasma thiols, homocysteine is the most often target o f analysis. 
Elevated concentration o f total homocysteine in plasma (hiperhomocysteinemia, 
concentration above 15 nmol/ml) is recognized as an independent risk factor for 
premature developm ent o f cardiovascular diseases. However, there is an evident 
need to measure different species of thiols in order to fully understand the 
dynamic relationship between homocysteine and other biologically important 
thiols and disulfides in plasma. Alteration of the redox status o f homocysteine 
rapidly affects and is related to the total thiol redox status in plasma. This 
observations can be explained by continuos redox and disulfide exchange 
reactions in plasma. The comprehensive measurement of the reduced thiol 
fraction has proven to be problematic because of low concentration and 
susceptibility to oxidation. This promted us to develop a new HPLC methods 
with UV detection for determining different species of thiols in plasma [16,17] 
and urine [27]. The methods rely on transformation o f thiols to stable 
2-S-quinolinium derivatives in the reaction with CM QT reagent, and separation 
and quantitation by ion-pairing reversed-phase HPLC. Oxidized species are 
converted to their thiol forms by reduction before derivatization. To circumvent 
the loss o f reduced form ex vivo due to oxidation, the CM QT reagent is added to 
whole blood immediately after collection and prior to separation o f plasma from 
erythrocytes in order to block the reactive -SH groups. Typical chromatograms
for standard mixture and reduced fraction of main plasma thiols are shown in 
Fig. 4.
Another new HPLC method (Fig. 5) enables simultaneous determination 
of N-acetylcysteine and four main endogenous plasma thiols [25]. 
N-acetylcysteine is administered orally or injected intraperitoneally in order to 
increase the free radical scavenging power of human plasma or in the capacity of 
mucolytic agent.
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Fig. 4. Typical chromatogram o f  main plasma thiols. (A) water standard solution, concentration of  
analytes and internal standards in final analytical solution 20 nmol/ml in respect to each; (B) 
reduced thiols in plasma. Peaks: I, glutathione -  CMQT 2.51 nmol/ml; 2, hom ocysteine -  CMQT 
0.31 nmol/ml; 3, 2-mercaptopropionic acid -  CMQT (internal standard) 3.33 nmol/ml; 
4, 3-mercaptopropionic acid -  CMQT (internal standard) 3.33 nmol/ml; 5, cysteine -  CMQT 12.1 
nmol/ml; 6, cysteinylglycine -  CMQT derivative 2.36 nmol/ml; 7, excess o f CMQT
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Fig. 5. Typical HPLC chromatogram of human plasma spiked with 40 nmol/ml of  
N-acetylcysteine and 400 nmol/ml 3 ,3 ’-dithiodipropionic acid (internal standard) and derivatized 
with 2-chloro-1-methylquinolinium tetrafluoroborate (CMQT). Peaks: 1, S-quinolinium derivative 
of N-acetylcysteine; 2, S-quinolinium derivative o f glutathione; 3, S-quinolinium derivative of  
homocysteine; 4, S-quinolinium derivative o f 3-mercaptopropionic acid; 5, S-quinolinium  
derivative o f  cysteine; 6, S-quinolinium derivative o f  cysteinylglycine; 7, excess o f  CMQT
6. Conclusions
The majority o f bioanulytical methods do not use just one simple 11PCE 
or HPLC separation step, but rather involve several sample pretreatment steps 
which simplify the matrix, and often preconcentrate and chemically modifity the 
analytes. HPCE following extensive clean -  up involves 110 less effort than 
performing an HPLC separation, but for certain applications, such as chiral 
separations, there are clearly attractions in using HPCE. Minimal preparation by 
removal o f proteins is satisfactory, provided that the analyte concentration is 
within the useful range of the detection system in use. In the case o f biological 
thiols, for the reason of their susceptibility to oxidation and lack the structural 
properties necessary for the production of signals compatible with common 
HPCE or HPLC detectors, derivatization is almost always performed.
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